• About Us
  • Investor Portal Home
  • Our Companies
  • Board of Directors
  • News and Events
  • Our ESG Policy
  • Careers in Ergomed
  • Contact Us
CLOSE
Visit Our Clinical Research Site
  • Careers at Ergomed
  • Contact Us
  • Search
  • English
Ergomed Investors
  • Open menu
  • About Us
  • News and Events
  • Our Services
  • Investor Portal
CLOSE
  • Investor Portal Home
  • AIM Rule 26
  • Board of Directors
  • Company Information
  • Results Centre
  • Regulatory News
  • Investor Portal Home
  • AIM Rule 26
  • Board of Directors
  • Company Information
  • Results Centre
  • Regulatory News
  • Investor Portal Home
  • AIM Rule 26
  • Board of Directors
  • Company Information
  • Results Centre
  • Regulatory News
  • Investor Portal Home
  • AIM Rule 26
  • Board of Directors
  • Company Information
  • Results Centre
  • Regulatory News
  • Investor Portal Home
  • AIM Rule 26
  • Board of Directors
  • Company Information
  • Results Centre
  • Regulatory News

Shareholder Communications

  • Results Centre
  • AIM Rule 26
  • Board of Directors
  • Company Information
  • Corporate Governance
  • Advisors
  • Analyst Coverage
  • Edison Reports
  • Financial Calendar
  • Regulatory News
  • Regulatory News Alerts
  • Shareholder Communications
  • Warning to Shareholders
17 May 2019

Notice of AGM 2019

Read more

17 May 2019

Form of Proxy – AGM 2019

Read more

11 July 2018

Letter to Shareholders Regarding Resignation of Deloitte LLP as Auditor of Ergomed plc

Read more

25 May 2018

Form of Proxy – AGM 2018

Read more

25 May 2018

Notice of AGM 2018

Read more

8 May 2018

Notice of AGM 2017

Read more

2 June 2016

Form of Proxy – AGM 2016

Read more

2 June 2016

Notice of AGM 2016

Read more

5 May 2016

Circular – Proposed Acquisition of Haemostatix Ltd, Placing and Notice of General Meeting

Read more

9 July 2014

Admission Document

Read more

Posts navigation

Newer posts

Our Headquarters:
1 Occam Court, The Surrey Research Park
Guildford, Surrey GU2 7HJ
United Kingdom

Contact Us
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Our Company

  • About Us
  • Our Companies
  • Reports
  • Executive Management Team
  • News and Events
  • Responsible business – Our approach to ESG
  • Contact Us
  • Download Ergomed Brochure

Investor Portal

  • Investor Portal Home
  • AIM Rule 26
  • Board of Directors
  • Company Information
  • Results Centre
  • Regulatory News

Our Companies

  • Ergomed Clinical Research
  • PrimeVigilance
  • Careers and opportunities
© Ergomed plc 2023
  • Sitemap
  • Modern Slavery Statement
  • Privacy policy
  • Legal information
Cleantalk Pixel

This site uses cookies to personalize and customize your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

I accept
Cookie Settings
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

Necessary Analytics Marketing Performance Privacy Policy

Technical Cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec


Third Vendor Analytics
  • wow.anonymousid
  • wow.utmvalues

Google Analytics
  • _ga
  • _gid
  • _gat

Third Vendor Session
  • wow.session


Third Vendor Marketing
  • wow.trackingdata
  • wow.data


Cloudflare
  • __cfduid

Third Vendor Load Balancing
  • wow.schedule

Decline all Services
Accept all Services
Secured By miniOrange